Quest Diagnostics Incorporated (DGX) vs Incyte Corporation (INCY)
A side-by-side comparison of Quest Diagnostics Incorporated and Incyte Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.
DGX
Quest Diagnostics Incorporated
$236.44HealthcareDelayed quote: Sep 24, 2026, 3:59 PM EDT
INCY
Incyte Corporation
$124.44HealthcareDelayed quote: Sep 24, 2026, 4:00 PM EDT
Total return — DGX vs INCY
growth of $100 · dividends reinvested · last 10yDGX +250.4% (+13.4%/yr)INCY +45.0% (+3.8%/yr)DGX compounded faster over this window
DGX INCY
DGX vs INCY: by the numbers
- •DGX is the larger company ($26.10B vs $25.22B market cap).
- •INCY trades at the lower trailing earnings multiple (15.85 vs 25.10 P/E), one valuation lens rather than an overall verdict.
- •INCY converts more revenue to profit (27.71% vs 9.19% net margin).
- •INCY grew revenue faster over the past five years (16.43% vs 0.89% CAGR).
- •DGX pays a dividend (1.41% yield), while INCY has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | DGX | INCY |
|---|---|---|
| P/E ratio | 25.10 | 15.85 |
| Forward P/E | 21.13 | 33.08 |
| P/S ratio | 2.26 | 4.33 |
| P/B ratio | 3.47 | 3.98 |
| EV / EBITDA | 15.95 | 10.99 |
| FCF yield | 4.67% | 7.61% |
Profitability
| Metric | DGX | INCY |
|---|---|---|
| Gross margin | 33.15% | 92.62% |
| Operating margin | 14.14% | 31.57% |
| Net margin | 9.19% | 27.71% |
| ROE | 14.13% | 25.41% |
| ROIC | 8.25% | 22.95% |
Dividends
| Metric | DGX | INCY |
|---|---|---|
| Dividend yield | 1.41% | N/A |
| Payout ratio | 35.24% | N/A |
Growth (annualized)
| Metric | DGX | INCY |
|---|---|---|
| Revenue CAGR (5Y) | 0.89% | 16.43% |
| EPS CAGR (5Y) | -3.65% | 21.19% |
| FCF CAGR (5Y) | -10.89% | 33.69% |
| Total return CAGR (5Y) | 10.93% | 11.30% |
Frequently asked
- Which has the lower trailing P/E, DGX or INCY?
- INCY has the lower trailing P/E: DGX trades at 25.10 and INCY at 15.85. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, DGX or INCY?
- Over the past five years, INCY grew revenue faster — DGX at a 0.89% CAGR versus INCY at 16.43%.
- Does DGX or INCY pay a bigger dividend?
- DGX pays a dividend (1.41% yield), while INCY has no payments in the available dividend history.
- Is DGX or INCY more profitable?
- INCY runs the higher net margin — DGX at 9.19% versus INCY at 27.71%.
- How have DGX and INCY total returns compared?
- Over the past 10 years, DGX delivered 13.51% and INCY delivered 4.38% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Quest Diagnostics P/E ratioIncyte P/E ratioQuest Diagnostics dividend yieldQuest Diagnostics ROEIncyte ROEQuest Diagnostics operating marginIncyte operating marginQuest Diagnostics revenue growthIncyte revenue growthQuest Diagnostics free cash flowIncyte free cash flow
Quest Diagnostics & Incyte appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.